4 months ago
MANE
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Analyst Ranking
Top 16%
#874 out of 5550 analysts
Average Return
+17.5%
Win Rate
41%26 out of 63
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | +736.48% | $9.27 | $77.50 | 2025-04-11 - 2026-04-10 | Strong Buy |
Mbx Biosciences IncMBX | +365.99% | $14.72 | $68.57 | 2025-08-15 - 2026-08-14 | Strong Buy |
Oruka Therapeutics IncORKA | +267.21% | $26.38 | $96.87 | 2025-11-13 - 2026-10-30 | Strong Buy |
Atyr Pharma IncATYR | +212.57% | $70.00 | $218.80 | 2024-09-05 - 2025-09-04 | Strong Buy |
Veradermics IncMANE | +199.64% | $46.62 | $139.69 | 2026-03-02 - 2026-10-30 | Strong Buy |
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
5 months ago
NRIX
6 months ago
KNSA
7 months ago
ALLO
7 months ago
CTMX
8 months ago
BIOA
8 months ago
KRYS
a year ago
NKTR
3 years ago
VKTX
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $3.00 | +398.34% | Upgrades | 3 months ago |
Veradermics IncMANE | 2 | Strong Buy | $182.00 | +30.29% | Maintains | 4 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $45.00 | +67.91% | Maintains | 5 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $11.00 | +228.36% | Initiates Coverage On | 5 months ago |
Kailera Therapeutics IncKLRA | 1 | Strong Buy | $48.00 | +273.25% | Initiates Coverage On | 6 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 4 | Strong Buy | $71.00 | -23.03% | Maintains | 6 months ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $10.00 | +747.46% | Maintains | 7 months ago |
Replimune Group IncREPL | 3 | Hold | $2.00 | -88.64% | Downgrades | 7 months ago |
Cytomx Therapeutics IncCTMX | 4 | Strong Buy | $16.00 | +583.76% | Maintains | 7 months ago |
Bioage Labs IncBIOA | 3 | Strong Buy | $62.00 | +956.22% | Upgrades | 8 months ago |
Krystal Biotech IncKRYS | 2 | Strong Buy | $371.00 | +11.65% | Maintains | 8 months ago |
Protagonist Therapeutics IncPTGX | 1 | Strong Buy | $118.00 | -18.54% | Maintains | 9 months ago |
Corvus Pharmaceuticals IncCRVS | 2 | Strong Buy | $42.00 | +318.74% | Maintains | 9 months ago |
Nektar TherapeuticsNKTR | 11 | Strong Buy | $121.00 | +211.29% | Maintains | a year ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $45.00 | -53.55% | Initiates Coverage On | a year ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Tourmaline Bio IncTRML | 3 | Hold | $47.50 | N/A | Downgrades | a year ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $564.00 | N/A | Maintains | a year ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $680.00 | N/A | Maintains | a year ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $36.00 | N/A | Assumes | a year ago |
Lava Therapeutics NvLVTX | 1 | Hold | $1.50 | N/A | Downgrades | a year ago |
Verve Therapeutics IncVERV | 1 | Hold | $11.00 | N/A | Downgrades | a year ago |
Curevac NvCVAC | 1 | Hold | $5.00 | N/A | Downgrades | a year ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Wave Life Sciences IncWVE | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Kura Oncology IncKURA | 2 | Strong Buy | $28.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $7.00 | N/A | Upgrades | 2 years ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | 2 years ago |
Novavax IncNVAX | 2 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $129.00 | N/A | Maintains | 2 years ago |
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | N/A | Initiates Coverage On | 3 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 3 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | N/A | Maintains | 3 years ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 5 years ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $4.00 | N/A | Upgrades | 5 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 6 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $210.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.